Sjogrens

Immunology

4 drugs in development·2 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(1)

Drug	Company
supportive care	GH Research PLC (GHRS)

Phase 4(3)

Drug	Company
Efgartigimod PH20 SC	ARGENX SE (ARGX)
treatment with amiodarone at a dose 100 mg per day	GH Research PLC (GHRS)
treatment with amiodarone at a dose 400 mg per day	GH Research PLC (GHRS)

BioSniper tracks 4 drugs in development for Sjogrens across 2 companies.

There are 1 clinical trial targeting Sjogrens tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.